Johnson & Johnson (JNJ) Gross Margin (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Gross Margin came in at 66.31% in Q1 2026, down 8.0% year-on-year from 72.08% in Q1 2025, and down 1.85% quarter-over-quarter from 67.56% in Q4 2025.

Johnson & Johnson (JNJ) Gross Margin (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Gross Margin across 18 years of filings, most recently posting 66.31% for Q1 2026.

  • Gross Margin for Q1 2026 came in at 66.31%, down 8.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 67.82% (down 48.0% YoY), and the FY2025 annual result was 67.88%, down 119.0% from the prior year.
  • Gross Margin came in at 66.31% for Q1 2026 at Johnson & Johnson, down from 67.56% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 69.97% in Q3 2023 to a low of 66.31% in Q1 2026.
  • The 5-year median for Gross Margin is 69.01% (2024), against an average of 68.6%.
  • Across the five-year window, Gross Margin soared 155 bps in 2024 and slumped 315 bps in 2025, its largest moves.
  • Johnson & Johnson's Gross Margin stood at 69.13% in 2022, then declined by 1 bps to 68.23% in 2023, then gained by 0 bps to 68.35% in 2024, then slipped by 1 bps to 67.56% in 2025, then dropped by 2 bps to 66.31% in 2026.
  • The last three Gross Margin figures came in at 66.31% (Q1 2026), 67.56% (Q4 2025), and 69.56% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn 75.42%
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn 81.93%
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn 66.31%
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn 71.88%
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn 74.24%
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn 68.16%
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 79.24%
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn -51.69%
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn 70.22%
10 Novartis Ag 112.59 Bn 111.90 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 66.31%
Dec 28, 2025 67.56%
Sep 28, 2025 69.56%
Jun 29, 2025 67.87%
Mar 30, 2025 66.40%
Dec 29, 2024 68.35%
Sep 29, 2024 69.01%
Jun 30, 2024 69.40%
Mar 31, 2024 69.55%
Dec 31, 2023 68.23%
Oct 1, 2023 69.06%
Jul 2, 2023 69.97%
Apr 2, 2023 68.00%
Jan 1, 2023 69.49%
Oct 2, 2022 69.13%
Jul 3, 2022 68.73%
Apr 3, 2022 69.67%
Oct 3, 2021 68.93%
Jul 4, 2021 67.45%
Apr 4, 2021 68.36%